Photo from wikipedia
Ixekizumab (Taltz) is an anti‐interleukin‐17A monoclonal antibody therapy for the treatment of adults with plaque psoriasis or psoriatic arthritis. This article discusses its efficacy and place in therapy. Click to show full abstract
Ixekizumab (Taltz) is an anti‐interleukin‐17A monoclonal antibody therapy for the treatment of adults with plaque psoriasis or psoriatic arthritis. This article discusses its efficacy and place in therapy.
Keywords:
psoriatic arthritis;
psoriasis psoriatic;
ixekizumab;
plaque psoriasis
Journal Title: Prescriber
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Prescriber
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!